You are here: All Products  > Data from Qilu Pharma’s Approved ALK Inhibitor for NSCLC Published in Journal

Data from Qilu Pharma’s Approved ALK Inhibitor for NSCLC Published in Journal

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products